Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Update

Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 477,700 shares, an increase of 123.3% from the May 15th total of 213,900 shares. Approximately 8.7% of the shares of the company are short sold. Based on an average daily trading volume, of 187,900 shares, the short-interest ratio is currently 2.5 days.

Semler Scientific Stock Performance

Shares of NASDAQ SMLR remained flat at $38.32 during trading on Friday. The company’s stock had a trading volume of 534,031 shares, compared to its average volume of 547,605. The firm has a 50 day moving average of $27.46 and a 200-day moving average of $36.59. The company has a market cap of $270.92 million, a P/E ratio of 13.73 and a beta of 0.96. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $53.38.

Semler Scientific (NASDAQ:SMLRGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.78 earnings per share (EPS) for the quarter. Semler Scientific had a return on equity of 30.36% and a net margin of 32.92%. The business had revenue of $15.90 million during the quarter.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on SMLR shares. TheStreet raised Semler Scientific from a “c+” rating to a “b-” rating in a report on Friday, March 1st. Lake Street Capital raised Semler Scientific to a “strong-buy” rating in a report on Wednesday, May 8th.

Get Our Latest Stock Report on SMLR

Hedge Funds Weigh In On Semler Scientific

Several hedge funds have recently bought and sold shares of SMLR. Conestoga Capital Advisors LLC grew its position in shares of Semler Scientific by 4.2% in the fourth quarter. Conestoga Capital Advisors LLC now owns 30,499 shares of the company’s stock valued at $1,351,000 after purchasing an additional 1,230 shares during the last quarter. AJOVista LLC acquired a new stake in shares of Semler Scientific in the fourth quarter valued at about $58,000. Tower Research Capital LLC TRC grew its position in shares of Semler Scientific by 250.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,103 shares of the company’s stock valued at $93,000 after purchasing an additional 1,503 shares during the last quarter. Horizon Investment Services LLC grew its position in shares of Semler Scientific by 35.8% in the first quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock valued at $244,000 after purchasing an additional 2,203 shares during the last quarter. Finally, Acadian Asset Management LLC grew its position in shares of Semler Scientific by 2.8% in the third quarter. Acadian Asset Management LLC now owns 80,134 shares of the company’s stock valued at $2,031,000 after purchasing an additional 2,218 shares during the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Further Reading

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.